Insulin actions in the mesolimbic dopamine system
If you are considering losing weight and are frustrated with diet plans and exercise, you may qualify for these medications
The 6-variable model includes patient age (U-shaped relationship), diabetes type (nearly doubled risk with type 1 diabetes), HbA 1c (U-shaped relationship), creatinine clearance (small increase in risk with worse renal function), severe hypoglycemia within the prior year (4-fold higher risk), and insulin use (2.3-fold higher risk).[108] While clinical practice guidelines recommend raising glycemic targets for patients at high risk for hypoglycemia,[17] this strategy alone may not be sufficient.[109, 110] A more effective approach may be to proactively de-intensify treatment regimens of overtreated patients.[111, 112] Potential overtreatment of adults with type 2 diabetes is common, including among older adults, patients with advanced kidney disease and dementia, and patients with high clinical complexity.[83, 113115] These patients are at highest risk for hypoglycemia, yet because of their multi-morbidity and limited life expectancy they also derive less benefit from intensive glycemic control
FDA Approval and Proven Real-World Safety Semaglutide is fully FDA-approved under two branded formulations Ozempic for type 2 diabetes and Wegovy for chronic weight management with years of post-market safety data covering millions of patients globally
